Project Grant HT94252310008
Award Date 2/1/23
Completion Date 1/31/25
Dollars Obligated $298K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Columbia, SC 29208, USA
Similar Awards
- The Defense Health Agency awarded a $755,001 Project Grant to The Medical University of South Carolina (MUSC) under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, running from July 1, 2023 to June 30, 2026, supports research on microsomal glutathione transferase as a new target in melanotic melanoma. As a public institution of higher education, MUSC conducts biomedical research and provides healthcare services, with a mission to preserve and optimize...
- The Medical University of South Carolina (MUSC) was awarded a $792,245 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "LEVERAGING LINEAGE ADDICTION: NUCLEAR DELIVERY OF THERAPEUTIC TRANSGENES RESPONSIVE TO ONCOGENIC TRANSCRIPTION FACTOR OVEREXPRESSION," will fund research focused on developing innovative gene therapy approaches to treat various medical conditions. The award has a performance...
- This $1,038,931 federal Project Grant was awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant funds research conducted by The Medical University of South Carolina (MUSC) to study SETD2 deficiency and its potential to increase sensitivity to BCL-XL inhibition, which may lead to new treatment approaches. The award has a performance period from September 30, 2024 to September 29, 2028. MUSC, a public university and major...
- The Defense Health Agency (DHA) awarded The Medical University of South Carolina (MUSC) a $1.65 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) on April 15, 2026, for research titled "Leveraging Epitranscriptomics and Translation Reprogramming to Prevent or Overcome Drug Resistance in Breast Cancer." The three-year award, which extends through April 14, 2029, supports hypothesis-driven biomedical research designed to develop innovative...
- Federal Grant Award Summary The University of Southern California received a $871,500 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for research on YAP inhibition as a treatment for vestibular schwannoma. The award, effective September 1, 2025, through August 31, 2028, will support basic and applied biomedical research designed to investigate innovative medical solutions addressing this neurological condition....
- Federal Project Grant Award Summary The University of Southern California received a $1,092,695 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the "Convergent Science Virtual Cancer Center," with performance extending from August 1, 2025 through July 31, 2029. This award supports basic, applied, and advanced biomedical research designed to transform healthcare for military service members and the American...
- The Defense Health Agency awarded Duke University a $804,999 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research on "DETECTING MISSED METASTASES FROM NOMINALLY EARLY-STAGE MELANOMAS WITH PUMP-PROBE MICROSCOPY". The award runs from September 1, 2023 to August 31, 2026. The Project Grant enables Duke's research to transform health care for Service Members and the American public through innovative and impactful biomedical research...
- This federal Project Grant award in the amount of $906,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant titled "Defining and Targeting Cancer Cell-Intrinsic Vulnerabilities in Renal Cell Carcinoma" will be performed by the Medical University of South Carolina (MUSC) from August 1, 2024 to July 31, 2027. Through this funding, MUSC will conduct innovative biomedical research to study novel therapies...
- Federal Grant Award Summary The Medical University of South Carolina (MUSC) received a $1.19M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on immune signatures associated with immunotherapy response in metastatic renal cell cancer. The three-year project, effective September 1, 2025 through August 31, 2028, will be performed at MUSC's Charleston, South Carolina facility. The research aims to...
- The University of Southern California (USC) Department of Contracts and Grants Division was awarded a $331,630 Project Grant by the Defense Health Agency under the "Military Medical Research and Development" (CFDA 12.420) program. The grant supports research into mRNA delivery for polycystic kidney disease, with a period of performance from November 15, 2023 to November 14, 2025. As a leading private research university, USC leverages its expertise in engineering, health sciences,...